WHAT DOES Faringosept® 10 mg CONTAIN?

Active substance in the composition of Faringosept® 10 mg and Faringosept® Lemon

Ambazone* is one of the oldest antimicrobials. The first research was initiated in 1935 by Paul Ehrlich, a Nobel Prize-winning German physician, who worked in the fields of haematology, immunology, and antimicrobial chemotherapy. Ambazone is an active substance with famous “parents”, being invented in 1955 by Domagk, who resumed and continued the German physician’s research and introduced to the world a drug that would serve as the basis of all antibacterial sulphonamides.

AMBAZONE (active substance) belongs to the group of local antiseptics, medicines for the oropharyngeal space.

Ambazone is an active antiseptic, especially against streptococci, pneumococci, pathogenic microorganisms with an important role in triggering infections of the oral cavity and upper respiratory tract.* Ambazone has moderate action against staphylococci. The drug does not cause dysbacteriosis in the digestive tract.

**Bacteriologia, Virusologia, Parazitologia, Epidemiologia, Vol 52, nr. 1-2, 2007.

Ambazone is indicated for acute infections located in the oropharyngeal space (pharyngitis, gingivitis, stomatitis, angina) and tonsillectomy post-operative care.

References:
National Agency for Medicines and Medical Devices of Romania - official online platform
SmPC and Package Leaflet

How does Faringosept® 10 mg work?

Faringosept® is an antiseptic drug used as an adjuvant in the treatment of acute infections of the oral cavity and pharynx:

• Gingivitis
• Pharyngitis
• Tonsillitis
• Tonsillectomy post-operative care (after the surgical removal of tonsils)

Ambazone acts on bacterial multiplication, preventing the worsening of the infection and speeding up healing.

All studies conducted within the Department of Clinical Pharmacology and Pharmacokinetics at Terapia are carried out in accordance with the principles defined in the “Good Clinical Practice” guidelines, and in the “Declaration of Helsinki for Human Rights”, all of which are designed to protect the rights, health and dignity of individuals participating in clinical trials.

In recent years, the Department of Clinical Pharmacology and Pharmacokinetics at Terapia has successfully passed inspections conducted by competent authorities in the field, both in Romania (National Agency for Medicines and Medical Devices of Romania) and in other countries where our company’s tested products are marketed. It concerns the United States Food and Drug Administration (US-FDA) and the Brazilian Health Regulatory Agency (ANVISA).

WHY Faringosept and Faringosept Lemon?

FARINGOSEPT® IS THE ONLY MEDICINE AUTHORIZED IN ROMANIA CONTAINING AMBAZONE

• Speeds-up healing of oropharyngeal infections
• Action against several types of bacteria
• Antiseptic

WHEN IS IT RECOMMENDED?

• Pharyngitis
• Tonsillitis
• Gingivitis
• Post-tonsillectomy treatment

HOW TO TAKE IT?

Posology and method of administration:

• Adults:
  The recommended dose is 3-5 tablets of Faringosept Lemon 10 mg (30-50 mg ambazone) per day for 3-4 days.
• Children and adolescents:
  The recommended dose for the children and adolescents between 14 and 18 years is 1 tablet of Faringosept Lemon 10 mg 3 times a day (30 mg ambazone) for 3-4 days.

These are medicines and can be acquired without a prescription. It is recommended to carefully read the leaflets and the information on the packaging. For more information, we recommend consulting a healthcare professional. If unpleasant symptoms occur, contact your doctor or pharmacist. Advertising visa no. 8638/ 17.09.2026.